Ameriprise
NTUS

Ameriprise’s Natus Medical Inc NTUS Stock Holding History

Ameriprise’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-166,212
Closed -$5.45M – 4086
2022
Q2 		$5.45M Sell
166,212
-954,704
-85% -$30.2M ﹤0.01% 2213
2022
Q1 		$29.4M Buy
1,120,916
+211,848
+23% +$5.17M 0.01% 1083
2021
Q4 		$21.6M Buy
909,068
+52,919
+6% +$1.31M 0.01% 1346
2021
Q3 		$21.5M Buy
856,149
+72,647
+9% +$1.85M 0.01% 1213
2021
Q2 		$20.4M Buy
783,502
+61,174
+8% +$1.66M 0.01% 1343
2021
Q1 		$18.5M Buy
722,328
+463,198
+179% +$11.9M 0.01% 1382
2020
Q4 		$5.19M Buy
259,130
+11,056
+4% +$217K ﹤0.01% 2245
2020
Q3 		$4.25M Sell
248,074
-14,917
-6% -$282K ﹤0.01% 2202
2020
Q2 		$5.74M Sell
262,991
-40,181
-13% -$920K ﹤0.01% 1962
2020
Q1 		$7.01M Sell
303,172
-63,784
-17% -$1.85M ﹤0.01% 1669
2019
Q4 		$12.1M Buy
366,956
+13,986
+4% +$448K 0.01% 1593
2019
Q3 		$11.2M Sell
352,970
-27,295
-7% -$796K 0.01% 1610
2019
Q2 		$9.77M Buy
380,265
+28,081
+8% +$716K ﹤0.01% 1755
2019
Q1 		$8.94M Buy
352,184
+49,407
+16% +$1.47M ﹤0.01% 1786
2018
Q4 		$10.3M Buy
302,777
+14,121
+5% +$459K 0.01% 1579
2018
Q3 		$10.3M Buy
288,656
+17,772
+7% +$627K ﹤0.01% 1847
2018
Q2 		$9.35M Buy
270,884
+35,745
+15% +$1.25M ﹤0.01% 1801
2018
Q1 		$7.91M Buy
235,139
+11,112
+5% +$352K ﹤0.01% 1840
2017
Q4 		$8.56M Sell
224,027
-13,595
-6% -$543K ﹤0.01% 1727
2017
Q3 		$8.91M Sell
237,622
-12,526
-5% -$442K ﹤0.01% 1666
2017
Q2 		$9.33M Sell
250,148
-231,921
-48% -$8.38M ﹤0.01% 1610
2017
Q1 		$19M Sell
482,069
-76,101
-14% -$2.86M 0.01% 1055
2016
Q4 		$19.4M Buy
558,170
+136,781
+32% +$5.37M 0.01% 1015
2016
Q3 		$16.6M Buy
421,389
+45,272
+12% +$1.81M 0.01% 1051
2016
Q2 		$14.2M Buy
376,117
+35,302
+10% +$1.18M 0.01% 1133
2016
Q1 		$13.1M Sell
340,815
-778
-0.2% -$29K 0.01% 1217
2015
Q4 		$16.4M Buy
341,593
+29,565
+9% +$1.37M 0.01% 1058
2015
Q3 		$12.3M Buy
312,028
+49,145
+19% +$2.09M 0.01% 1289
2015
Q2 		$11.2M Buy
262,883
+88,500
+51% +$3.53M 0.01% 1492
2015
Q1 		$6.88M Sell
174,383
-3,842
-2% -$142K ﹤0.01% 1879
2014
Q4 		$6.42M Buy
178,225
+2,495
+1% +$83.8K ﹤0.01% 1887
2014
Q3 		$5.18M Buy
175,730
+25,826
+17% +$713K ﹤0.01% 2009
2014
Q2 		$3.77M Buy
149,904
+26,055
+21% +$644K ﹤0.01% 2244
2014
Q1 		$3.2M Buy
123,849
+3,269
+3% +$82.4K ﹤0.01% 2289
2013
Q4 		$2.71M Buy
120,580
+14,676
+14% +$283K ﹤0.01% 2329
2013
Q3 		$1.5M Sell
105,904
-6,800
-6% -$90.9K ﹤0.01% 2550
2013
Q2 		$1.54M Buy
+112,704
New +$1.54M ﹤0.01% 2470

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Ameriprise's NTUS Position: Q3 2022 in Review

Ameriprise sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 166,212 shares — an estimated $5.45M sold.

Ameriprise first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $29.4M in Q1 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Ameriprise reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Ameriprise sold 166,212 Natus Medical Inc shares in Q3 2022, an estimated $5.45M.
  • Ameriprise first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
  • Ameriprise's Natus Medical Inc position peaked at $29.4M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Ameriprise's 13F filing for Q3 2022, filed 14 Nov 2022.